Charles Schwab Investment Management Inc Sesen Bio, Inc. Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.89 $170,158 - $398,528	-447,785 Reduced 86.83%	67,895 $56,000
Q4 2021 Feb 11, 2022	BUY	$0.73 - $1.28 $21,998 - $38,572	30,135 Added 6.21%	515,680 $421,000
Q3 2021 Nov 16, 2021	BUY	$0.77 - $4.91 $42,481 - $270,889	55,171 Added 12.82%	485,545 $386,000
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.66 $815,359 - $1.74 Million	374,018 Added 663.67%	430,374 $1.99 Million
Q4 2020 Feb 16, 2021	BUY	$1.01 - $1.77 $45,809 - $80,280	45,356 Added 412.33%	56,356 $77,000
Q2 2019 Aug 09, 2019	SELL	$0.95 - $2.46 $35,488 - $91,895	-37,356 Reduced 77.25%	11,000 $17,000
Q1 2019 May 14, 2019	BUY	$0.69 - $1.47 $33,365 - $71,083	48,356 New	48,356 $50,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.